Stocks › TNDM
TANDEM DIABETES CARE INC
TNDM·Nasdaq·
United States·USD
$17.46
+0.66 (+3.93%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
TNDM
TANDEM DIABETES CARE INC · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TNDMS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of TNDM by members of U.S. Congress · 10 on record · 2 in the last 12 months
Whale Activity
Position changes in TNDM reported for 2026-09-30 by 310 institutional filers
- Increased93
- New34
- Held45
- Decreased80
- Closed43
- No prior filing15
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 11.8M | $192.0M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.9M | $63.0M | decreased |
| First Light Asset Management, LLC | 3.3M | $53.0M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | $49.6M | decreased |
| GW&K Investment Management, LLC | 2.9M | $47.4M | increased |
| STATE STREET CORP | 2.9M | $47.1M | increased |
| GOLDMAN SACHS GROUP INC | 2.6M | $41.8M | increased |
| Longaeva Partners L.P. | 2.4M | $38.5M | new |
| UBS Group AG | 2.2M | $35.8M | increased |
| ExodusPoint Capital Management, LP | 2.1M | $33.9M | increased |
| MILLENNIUM MANAGEMENT LLC | 2.1M | $33.8M | increased |
| Paradice Investment Management LLC | 2.0M | $32.7M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by TNDM insiders, by quarter · Form 4
Recent Insider Transactions
2,503 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| TWOMEY CHRISTOPHER JDirector · Director | Sale | −1,700 | $19.15 | $33K | Oct 27, 2026 | Form 4 ↗ |
| Vosseller LeighEVP & CHIEF FINANCIAL OFFICER | Tax withholding | −942 | $22.72 | $21K | Aug 15, 2026 | Form 4 ↗ |
| Vosseller LeighEVP & CHIEF FINANCIAL OFFICER | Option exercise | +2,624 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Vosseller LeighEVP & CHIEF FINANCIAL OFFICER | Tax withholding | −537 | $22.72 | $12K | Aug 15, 2026 | Form 4 ↗ |
| Vosseller LeighEVP & CHIEF FINANCIAL OFFICER | Option exercise | +1,496 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Sheridan John FPRESIDENT & CEO · Director | Tax withholding | −5,055 | $22.72 | $115K | Aug 15, 2026 | Form 4 ↗ |
| Sheridan John FPRESIDENT & CEO · Director | Option exercise | +9,934 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Sheridan John FPRESIDENT & CEO · Director | Tax withholding | −3,044 | $22.72 | $69K | Aug 15, 2026 | Form 4 ↗ |
| Sheridan John FPRESIDENT & CEO · Director | Option exercise | +5,982 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Morrison SusanEVP & Chief Admin. Officer | Tax withholding | −495 | $22.72 | $11K | Aug 15, 2026 | Form 4 ↗ |
| Morrison SusanEVP & Chief Admin. Officer | Option exercise | +1,730 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Morrison SusanEVP & Chief Admin. Officer | Tax withholding | −314 | $22.72 | $7K | Aug 15, 2026 | Form 4 ↗ |
| Morrison SusanEVP & Chief Admin. Officer | Option exercise | +1,097 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Kyrillos Jean-ClaudeEVP & Chief Operating Officer | Tax withholding | −535 | $22.72 | $12K | Aug 15, 2026 | Form 4 ↗ |
| Kyrillos Jean-ClaudeEVP & Chief Operating Officer | Option exercise | +1,010 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Gasser Elizabeth AnneEVP, Chief Strategy Officer | Tax withholding | −1,029 | $22.72 | $23K | Aug 15, 2026 | Form 4 ↗ |
| Gasser Elizabeth AnneEVP, Chief Strategy Officer | Option exercise | +1,917 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Gasser Elizabeth AnneEVP, Chief Strategy Officer | Tax withholding | −589 | $22.72 | $13K | Aug 15, 2026 | Form 4 ↗ |
| Gasser Elizabeth AnneEVP, Chief Strategy Officer | Option exercise | +1,097 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Carpenter RickEVP & Chief Technology Officer | Tax withholding | −820 | $22.72 | $19K | Aug 15, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding TNDM · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 4.1M | $62.3M | 0.06% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.2M | $33.0M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.8M | $27.4M | 0.03% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1.6M | $23.7M | 0.01% | Jun 30, 2026 |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 680.0K | $15.0M | 1.00% | Aug 31, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 763.5K | $14.9M | 0.04% | Jul 31, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 901.5K | $13.6M | 0.03% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 788.5K | $11.9M | 0.01% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 466.1K | $10.3M | 0.00% | Aug 31, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 644.8K | $9.7M | 0.06% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list TNDM's shares (CUSIP 875372203), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- John PetrySCHEDULE 13G/A · passive (13G) · 426.1K shares0.6%
Nov 16, 2026 · ↗ - Sessa Capital IM, L.P.SCHEDULE 13G/A · passive (13G) · 426.1K shares0.6%
Nov 16, 2026 · ↗ - Dmitry BalyasnySCHEDULE 13G · passive (13G) · 3.6M shares5.2%
Nov 16, 2026 · ↗ - Dames GP LLCSCHEDULE 13G · passive (13G) · 3.6M shares5.2%
Nov 16, 2026 · ↗ - Balyasny Asset Management Holdings LPSCHEDULE 13G · passive (13G) · 3.6M shares5.2%
Nov 16, 2026 · ↗ - BAM GP LLCSCHEDULE 13G · passive (13G) · 3.6M shares5.2%
Nov 16, 2026 · ↗ - BALYASNY ASSET MANAGEMENT L.P.SCHEDULE 13G · passive (13G) · 3.6M shares5.2%
Nov 16, 2026 · ↗ - GOLDMAN SACHS & CO. LLCSCHEDULE 13G · passive (13G) · 4.1M shares5.9%
Nov 9, 2026 · ↗ - THE GOLDMAN SACHS GROUP, INC.SCHEDULE 13G · passive (13G) · 4.1M shares5.9%
Nov 9, 2026 · ↗ - Voya Financial, Inc.SCHEDULE 13G/A · passive (13G) · 149.1K shares0.2%
Aug 6, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming tandem diabetes care as client
- THE NICKLES GROUP, LLCTANDEM DIABETES CARE · 2026 Q3 · MMM, BUD$50K
Filing ↗ - THE NICKLES GROUP, LLCTANDEM DIABETES CARE · 2026 Q2 · MMM, BUD$50K
Filing ↗ - THE NICKLES GROUP, LLCTANDEM DIABETES CARE · 2026 Q1 · MMM, BUD$50K
Filing ↗ - THE NICKLES GROUP, LLCTANDEM DIABETES CARE · 2025 Q4 · MMM, BUD$50K
Filing ↗ - THE NICKLES GROUP, LLCTANDEM DIABETES CARE · 2025 Q3 · MMM, BUD$50K
Filing ↗
Government Contracts
Federal awards to TANDEM DIABETES CARE INC · USAspending
No federal contract awards found for TANDEM DIABETES CARE INC.
U.S. Patents
Recent USPTO applications naming TANDEM DIABETES CARE INC
No USPTO patent applications found for TANDEM DIABETES CARE INC.
Annual Financials
From TNDM's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.01B | $940.2M | $747.7M | $801.2M | $702.8M |
| Operating income | -$187.3M | -$99.1M | -$233.2M | -$92.8M | $22.7M |
| Net income | -$204.7M | -$96.0M | -$222.6M | -$94.6M | $15.6M |
| Diluted EPS | -$3.04 | -$1.47 | -$3.43 | -$1.47 | $0.24 |
| Operating cash flow | -$9.7M | $24.2M | -$31.8M | $50.5M | $111.4M |
| Cash and equivalents | $90.6M | $69.2M | $58.9M | $172.5M | $71.2M |
| Total assets | $881.1M | $967.7M | $952.7M | $1.05B | $905.1M |
| Total liabilities | $725.9M | $704.6M | $639.0M | $612.8M | $472.0M |
| Shareholders' equity | $155.2M | $263.1M | $313.6M | $439.9M | $433.1M |
As TANDEM DIABETES CARE INC tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 19, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 1-for-10Reverse splitOct 10, 2017
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 8.01Other eventsNov 13, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 3.03, 5.02, 5.07, 9.01Modification of rights · Officer / director change · Shareholder voteMay 21, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeMay 15, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗ - 8-K · Items 5.03, 9.01Bylaw amendmentDec 30, 2025
EDGAR ↗
About TANDEM DIABETES CARE INC
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersSan Diego, CA
IncorporatedDE
SEC CIK0001438133 ↗





